Skip to main content
. 2020 Sep 23;97(7):E982–E991. doi: 10.1002/ccd.29281

TABLE 3.

Predischarge echocardiography and in‐hospital and 30‐day clinical outcomes

SAPIEN 3 Ultran = 141 SAPIEN 3n = 141 p value
Echocardiogram
Peak aortic velocity, m/s 2.0 ± 0.38 2.0 ± 0.40 .58
Peak aortic gradient, mmHg 19.0 ± 6.8 17.8 ± 6.9 .14
Mean aortic gradient, mmHg 10.3 ± 3.8 9.6 ± 3.9 .14
PVL
≥Mild 10 (7.2) 31 (22.3) .002
Moderate or severe 1 (0.72) 4 (2.9) .18
In‐hospital and 30‐day clinical outcomes
All‐cause mortality 3 (2.1) 3 (2.1) >.90
Stroke or TIA 2 (1.4) 2 (1.4) >.90
Bleeding complication
Life‐threatening or disabling 2 (1.4) 6 (4.3) .15
Major 5 (5.7) 9 (6.4) .62
Major vascular complication 7 (4.5) 16 (11.4) .05
Hemoglobin drop (before‐after), g/L 16.2 ± 8,9 19.3 ± 13.9 .03
AKI 1 (0.7) 3 (2.1) .32
Stage 1 1 (0.7) 3 (2.1) .32
Stage 2 0 (0) 0 (0) >.90
Stage 3 0 (0) 0 (0) >.90
Creatinine change (after‐before), μmol/L −11.8 ± 21.9 −7.2 ± 22.1 .08
Creatinine change (after / before) 0.89 ± 0.11 0.93 ± 0.20 .03
PMI 8 (5.7) 7 (5.0) .80
PMI without prior PMI 8 (6.3) 7 (5.6) .80
PMI with prior first‐degree block 3 (7.9) 3 (7.9) >.90
PMI with prior right bundle branch block 2 (16.7) 4 (26.7) .53
Post PR duration, ms 199.5 ± 40.4 191.0 ± 39.3 .15
PR duration (after‐before), ms 8.4 ± 32.5 6.0 ± 31.0 .42
Post QRS duration, ms 119.7 ± 30.3 118.5 ± 33.8 .77
QRS duration (after‐before), ms 7.5 ± 21.9 6.3 ± 20.5 .65
New left bundle branch block 19 (13.7) 22 (16.7) .49
LOS, days 2.7 ± 3.0 3.7 ± 4.3 .017
LOS after TAVR, days 2.0 ± 2.2 2.5 ± 2.5 .05
Device success 135 (95.7) 132 (93.6) .43
Any device failure requiring reintervention within 30‐days 0 (0) 1 (0.71) .32
30‐days mortality 3 (2.1) 3 (2.1) >.90

Notes: Values are n (%) or mean ± SD.

Abbreviations: AKI, acute kidney injury; LOS, length of hospital stay; PVL, paravalvular leakage; TAVR, transcatheter aortic valve replacement; TIA, transient ischemic attack. Other abbreviations as in Table 1.